Drugs / Pegsunercept
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00111423 | Aug 2002 → ? | rheumatoid arthritis | Amgen | Completed | No outcome recorded |
| Phase 2 | NCT00037700 | May 2001 → Dec 2002 | rheumatoid arthritis | Amgen | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pegsunercept | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00037700 ↗ |
| Known as | PEG sTNF-RI | “Pegsunercept (PEG sTNF-RI)” NCT00111423 ↗ |
| Known as | STNF-RI | ChEMBL registry synonym — accepted as the source's own label CHEMBL1743057 ↗ |
| Action | Inhibit | “TNF-alpha inhibitor” CHEMBL1743057 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL1743057 ↗ |
| Target | TNF | “TNF-alpha inhibitor” CHEMBL1743057 ↗ |